VGK stock forecast, quote, news & analysis

Key Takeaways

• VGK offers broad, passive exposure to developed European equities, tracking the FTSE Developed Europe All Cap Index across roughly 1,230 holdings of all market capitalizations.
• Financials (about 25%) and industrials (roughly 20%) anchor the portfolio, followed by healthcare, technology, and consumer staples.
• The fund carries a low expense ratio of 0.06% and holds top positions in ASML, HSBC, Roche, Novartis, Shell, and Nestlé, keeping it diversified rather than concentrated.
• Over the trailing 30 days, VGK has been little changed with a modest gain of about +0.9%, while the trailing quarter shows a decline of roughly -3.8%.
• The portfolio's value-oriented, financials-heavy tilt makes it sensitive to European interest rates, credit conditions, and global industrial demand.
• For more information on this ticker's Price Targets and Forecast, explore the additional analysis pages available for VGK.
• Discover Trending AI Robots to explore AI-driven trading strategies and ideas.

Vanguard FTSE Europe ETF (VGK) Overview

The Vanguard FTSE Europe ETF is a passively managed exchange-traded fund (ETF) designed to track the FTSE Developed Europe All Cap Index, a market-capitalization-weighted benchmark of common stocks issued by companies located in the major developed markets of Europe. Under normal circumstances, the fund invests at least 80% of its assets in stocks that make up the target index. Launched in March 2005 and issued by Vanguard, VGK is structured as a low-cost core holding for investors seeking diversified European equity exposure.

The fund holds approximately 1,230 securities and charges an expense ratio of 0.06%, among the lowest in its Europe Stock category. Its largest positions include ASML Holding, HSBC Holdings, Roche Holding, Novartis, Shell, Nestlé, Siemens, AstraZeneca, SAP, and Banco Santander, with the top ten names representing roughly 19% of assets. Sector allocation is led by financial services at about 25%, followed by industrials near 20%, healthcare around 12%, technology near 9%, and consumer defensive at roughly 7.5%. By geography, the United Kingdom, Germany, Switzerland, and France together account for the majority of exposure, with notable weight also in the Netherlands.

Industry and Thematic Landscape

European equities occupy a distinct position in global portfolios, typically trading at lower valuation multiples than their US counterparts while offering a heavier tilt toward financials, industrials, and dividend-paying names. This composition makes the region particularly responsive to monetary policy, banking sector profitability, and the pace of global manufacturing and trade. Financial institutions tend to benefit from higher net interest margins when rates rise, yet remain exposed to credit cycles and economic slowdowns. Industrials, in turn, are tied to capital spending, infrastructure investment, and export demand.

The European Central Bank's policy stance, inflation trends across the euro area, and energy prices are recurring structural influences on this market. The portfolio's semiconductor-equipment leader, ASML, links the fund to global technology capital expenditure, while its pharmaceuticals and consumer staples names provide defensive ballast. These characteristics shape both the fund's risk profile and its sensitivity to macroeconomic developments rather than any single company or sector.

Performance and Positioning Snapshot

VGK has traded in a relatively contained range in recent weeks. Over the trailing 30 days, the fund has been little changed, posting a modest advance of approximately +0.9%. This stability follows a more pronounced pullback earlier in the period, when the fund declined from a late-summer peak near its 52-week high before stabilizing in the mid-to-high $80s.

Looking at the trailing quarter, VGK has eased lower by roughly -3.8%. The fund climbed steadily through the summer, reaching its recent high in late August, before a broad decline into early autumn reflected softer European equity sentiment and rotation away from some of the region's more economically sensitive sectors. The recovery that followed has been gradual rather than trend-driven, consistent with the fund's diversified, market-cap-weighted structure. Because financials and industrials represent such a large share of holdings, their relative performance has been the dominant driver of the fund's recent behavior, with healthcare and technology names providing a partial offset.

AI Screener

Tickeron's AI Screener is an AI-powered stock and ETF discovery platform that helps investors scan thousands of securities using technical indicators, fundamentals, volatility measures, AI-generated signals, market trends, price patterns, and customizable filters. The tool is designed to surface trending securities, breakout candidates, and new trading opportunities more efficiently than manual screening, allowing users to narrow the investable universe by industry, performance characteristics, and signal quality. For investors seeking to complement a core European allocation or identify new ideas, the AI Screener offers a structured, data-driven starting point for further research.

2026 Outlook and Key Factors to Monitor

Several structural factors are likely to shape VGK during 2026. Interest rate expectations across the euro area and the United Kingdom remain central, given the fund's substantial financials weighting; the trajectory of policy rates and net interest margins will influence banking-sector earnings. Inflation trends and energy prices will similarly affect both consumer-facing businesses and industrial input costs. The semiconductor cycle, as reflected through ASML, ties the fund to global technology capital expenditure, while the pharmaceuticals and consumer staples segments offer defensive stability.

Investors should also monitor European economic growth, export demand from key trading partners, and the pace of capital flows into international equities, which can shift regional performance independently of fundamentals. Regulatory developments and banking-sector consolidation remain potential catalysts for the financials-heavy portfolio. None of these factors point to a single predetermined outcome; rather, they define the themes most likely to influence the fund's performance in the months ahead.

The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.

Disclaimers and Limitations